Visual hallucinations in patients with retinal disease

American Journal of Ophthalmology
I U ScottM F Folstein

Abstract

To investigate the prevalence and phenomenologic nature of visual hallucinations among patients with retinal disease and to investigate whether presence of hallucinations is a significant predictor of functional status, quality of life, and/or emotional distress after adjusting for visual acuity. Cross-sectional study. Eighty-six consecutive patients at the Wilmer Ophthalmologic Institute Retinal Vascular Center were interviewed using the Sickness Impact Profile, Community Disability Scale, General Health Questionnaire, Visual Phenomena Interview, Eysenck Personality Questionnaire, and Telephone Interview for Cognitive Status. The prevalence of visual hallucinations was 15.1%. Most were formed hallucinations in clear consciousness that lasted for seconds to minutes. The majority of patients had been experiencing visual hallucinations for less than 1 year (61.5%) or for 1 to 2 years (23.1%). Only two of the 13 patients with hallucinations had informed a physician of their hallucinations. Univariate analyses revealed that variables significantly associated with experiencing hallucinations were female sex, worse visual acuity, bilateral visual impairment, emotional distress, decreased functional status, and decreased quality of li...Continue Reading

References

Feb 1, 1979·Psychological Medicine·D P Goldberg, V F Hillier
Jun 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·R A Finlay-Jones, E Murphy
May 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·S HendersonG P Steele
Jul 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·D P GoldbergP Hesbacher
Jan 1, 1976·Medical Care·M BergnerB S Gilson
Jan 1, 1976·International Journal of Health Services : Planning, Administration, Evaluation·M BergnerJ R Morris
Nov 1, 1976·American Journal of Optometry and Physiological Optics·I L Bailey, J E Lovie
Feb 1, 1976·Medical Care·W E PollardB S Gilson
Dec 1, 1992·The American Journal of Psychiatry·S HolroydS C Wisniewski
Dec 1, 1991·Social Psychiatry and Psychiatric Epidemiology·A Y Tien
Feb 1, 1991·Psychological Medicine·S S Bassett, M F Folstein
Oct 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M J VandenburgJ D Stephens
Jan 1, 1988·Journal of Clinical Epidemiology·F C van Knippenberg, J C de Haes
Apr 1, 1988·Journal of Geriatric Psychiatry and Neurology·D A Casey, T Wandzilak
Jan 1, 1987·Journal of Chronic Diseases·L G Hart, R W Evans
Aug 12, 1988·JAMA : the Journal of the American Medical Association·N R Zweibel
Jul 1, 1986·International Clinical Psychopharmacology·L E Braddock, R N Heard
Jan 1, 1987·Journal of the American Geriatrics Society·F RosenbaumM Freedman
Nov 1, 1986·Headache·A O Schreiber, P C Calvert
Nov 1, 1985·American Journal of Public Health·L BergnerL A Cobb
Aug 23, 1973·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·D G Cogan
Feb 1, 1970·British Journal of Preventive & Social Medicine·D P GoldbergM Shepherd
May 1, 1971·The American Journal of Psychiatry·R G Fitzgerald
Mar 1, 1982·Archives of Internal Medicine·A J McSweenyR M Timms
May 1, 1982·Psychological Medicine·J Damas-MoraF A Jenner
Nov 1, 1980·Psychological Medicine·A Richardson, P Divyo
Mar 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·N J White
Jul 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·B SingermanM Folstein
Mar 1, 1994·Archives of Ophthalmology·I U ScottM F Folstein
May 5, 2001·American Journal of Ophthalmology·I U ScottK Bandeen-Roche
Apr 1, 1960·The American Journal of Psychiatry·E ZISKINDJ GOLDBERG

❮ Previous
Next ❯

Citations

May 16, 2014·The British Journal of Ophthalmology·Thomas M Cox, Dominic H ffytche
Oct 25, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·W Burke
Jun 1, 2005·The British Journal of Ophthalmology·S A Madill, D H Ffytche
Jun 7, 2005·Current Psychiatry Reports·Dominic H Ffytche
Feb 6, 2013·Journal of Neurology·Alberto LerarioVincenzo Silani
Jan 23, 2016·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Prabitha UrwylerUrs Peter Mosimann
Mar 1, 2005·Vision Research·Sigurros DavidsdottirAlison Lee
May 5, 2001·American Journal of Ophthalmology·I U ScottK Bandeen-Roche
Oct 24, 2007·Social Work in Health Care·Michèle Preyde, Tina Chapman
Jan 25, 2017·International Journal of Geriatric Psychiatry·Gregor RussellAlistair Burns
Sep 10, 2015·British Journal of Hospital Medicine·R NahasMjh Rahmani
Dec 23, 2006·Health and Quality of Life Outcomes·Jan Mitchell, Clare Bradley
Jan 27, 2009·Current Opinion in Neurology·Dominic H ffytche
Mar 28, 2020·Journal of Neurology, Neurosurgery, and Psychiatry·John O'BrienDominic Ffytche
Dec 5, 2019·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Srinivas MarmamulaPremNandhini Satgunam
Nov 9, 2019·The Journal of Nervous and Mental Disease·Huseyin BuyukgolDevrimsel Harika Ertem
Aug 12, 2021·Therapeutic Advances in Ophthalmology·Lee JonesMariya Moosajee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.